DRKS00010276已完成未知
Randomized, placebo-controlled, double-blind study to evaluate the influence of a combination product with L-arginine, folic acid, vitamin b6 and vitamin b12 on endothelial function in people with mild to moderate blood pressure elevation.
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 81
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 40 Years 至 65 Years（—）
- 性别
- All
入选标准
- •Slightly to moderatly elevated blood pressure (high-normal and subgroup „borderline grade 1: 130 to
- •=149 mmHg SBP), which is under assessment of other risk factors (end organ damage, diabetes,
- •clinically relevant cardiovascular diseases) not under need for mecial therapy (defined by the german
- •„Leitlinie zur Behandlung der arteriellen Hypertonie)
排除标准
- •-BMI >30 kg/m2
- •-Sleep-Apnoe
- •-Use of Antihypertensives or Statins
- •-Cardiovascular Diseases
- •- Use of drugs biasing the study outcome (Sildenafil, Vardenafil, Tadalafil, Nitrate), Estrogenes, etc.
- •- use of L-arginine or other supplements
研究者
相似试验
进行中（未招募）
不适用
Randomized, placebo-controlled, double-blind study to investigate the efficacy and safety of a 24-week inhalation treatment with glutathione in cystic fibrosis patients - GSH-4EUCTR2005-003870-88-DEMukoviszidose Institut gGmbH i. G.160
招募中
4 期
Randomized, placebo-controlled, double-blind study to evaluate the efficacy of 2LHERP® in patients with recurrent orofacial herpes infections.2024-514358-56-00Labo'Life Belgium140
进行中（未招募）
1 期
Randomized, placebo-controlled, double-blind study to evaluate the efficacy of 2LVERU®JUNIOR and 2LVERU® on the treatment of warts. EVAsION Studyon genital warts infectionMedDRA version: 21.1Level: LLTClassification code: 10010115Term: Common warts Class: 10029104MedDRA version: 20.0Level: LLTClassification code: 10035158Term: Plantar warts Class: 10029104MedDRA version: 20.0Level: LLTClassification code: 10047828Term: Warts Class: 10029104MedDRA version: 20.0Level: LLTClassification code: 10035150Term: Planar warts Class: 10029104CTIS2024-514476-40-00abo'Life Belgium162
进行中（未招募）
1 期
Randomized, placebo-controlled, double-blind study to evaluate the efficacy of 2LEBV® and 2LXFS® on asthenia in patients with an EBV infectioEpstein-Barr Virus infectionMedDRA version: 21.0Level: LLTClassification code: 10056907Term: EBV antigen positive Class: 10022891MedDRA version: 21.1Level: LLTClassification code: 10056906Term: EBV antibody positive Class: 10022891MedDRA version: 23.1Level: LLTClassification code: 10014078Term: EBV infection reactivation Class: 10021881MedDRA version: 20.0Level: LLTClassification code: 10014077Term: EBV infection Class: 10021881CTIS2024-514222-24-00abo'Life Belgium88
进行中（未招募）
1 期
Randomized, placebo-controlled, double-blind study to evaluate the efficacy of 2LPAPI® on the clearance of high-risk oncogenic HPV genital infections (PAPION study)MedDRA version: 25.0Level: LLTClassification code: 10086966Term: HPV screening Class: 100000004848MedDRA version: 25.0Level: LLTClassification code: 10086964Term: HPV infection Class: 100000004848MedDRA version: 20.0Level: SOCClassification code: 10038604Term: Reproductive system and breast disorders Class: 20MedDRA version: 20.0Level: SOCClassification code: 10021881Term: Infections and infestations Class: 1Human Papillomavirus infectionCTIS2024-513969-39-00abo'Life Belgium284